The Bob Harrington Show - Episode 38: HDL cholesterol, niacin, and AIM-HIGH with Dr Jim Stein

Summary: Is the concept of raising HDL cholesterol still pertinent in an era of well-controlled LDL levels via statin therapy? To address this question, our guest Dr Jim Stein reviews what evidence exists to indicate low HDL cholesterol may predict heart disease, how the drug niacin fits into the equation, and what the results of the AIM-HIGH trial might mean for this hypothesis.